 Connection
Mark Dacey to Treatment Outcome
This is a "connection" page, showing publications Mark Dacey has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.090 |
|
|
|
-
Larochelle MB, Smith J, Dacey MS. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series. Am J Ophthalmol. 2016 Jun; 166:149-153.
Score: 0.041
-
Henry CR, Walter SD, Chang PY, Warrow DJ, Naeini PE, Blinder KJ, Brevetti T, Yassine M, Dacey MS, Chu DS, Raiji VR, Rifkin LM, Shah M, Singer MA. Early adoption of triamcinolone acetonide suprachoroidal injection for uveitic macular edema: a physician survey. BMC Res Notes. 2024 Oct 23; 17(1):317.
Score: 0.019
-
Srivastava SK, Watkins TR, Nguyen QD, Sharma S, Scales DK, Dacey MS, Shah RE, Chu DS, Grewal DS, Faia LJ, Suhler EB, Genovese MC, Guo Y, Barchuk WT, Besuyen R, Dick AD, Rosenbaum JT. Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial. JAMA Ophthalmol. 2024 Sep 01; 142(9):789-797.
Score: 0.018
-
Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, Hanout M, Hassan M, Afridi R, Agarwal A, Halim MS, Do DV, Nguyen QD. Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis. Am J Ophthalmol. 2017 Nov; 183:71-80.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|